Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Zhang (Guangzhou, China), J. Liao (Guangzhou, China), Y. Chen (Guangzhou, China), Y. Chen (Guangzhou, China), J. Wang (Guangzhou, China). Mendelian Randomization Study Showed No Causality between Type 2 Diabetes and Pulmonary Hypertension. 1494

Member's Comments

No comment yet.

Related content which might interest you: Association between Metabolites Biomarkers and Pulmonary Hypertension:A Mendelian Randomization analysis Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Effects of Telerehabilitation on Dyspnea and Exercise Capacity in Patients with Type 2 Diabetes Mellitus Who Smoked. Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017 Type 2 Diabetes Acentuates the Impairment in the Lung Function and Mechanics in Elderly Source: Virtual Congress 2020 – Advances in lung function practice Year: 2020 Responses to Two Different High-Intensity Interval Exercise Training Protocols on Pulmonary Function and Respiratory Muscle Strength In Diabetes Mellitus Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients Year: 2021 Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Pulmonary Hypertension in Childhood Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Clinical Features of Pulmonary Hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Clinical Characteristics and Outcomes of Type 2 Diabetes and patients Infected with COVID-19 Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Risk Factors Associated to Cardiovascular Events after Bronchiectasis Exacerbation: A Prospective Study. Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020 Increased Risk of Heart Failure In Patients of Bronchiectasis – A Nationwide Population-Based Study Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019 Sarcoidosis-associated Pulmonary Hypertension: A London Cohort Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Risk Score for Subclinical COPD: The NHLBI Pooled Cohorts Study Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Disease Burden and Unmet Need in Asthma with Type 2 Inflammation Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics Year: 2017 Study on prevalence and associated factors of Diabetes Mellitus among Tuberculosis Patients in Iran Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 A Multidisciplinary Multicenter Study Evaluating Risk Factors, Prevalence and Characteristics of Post-COvid-19 Interstitial Lung Syndrome (PCOILS) Source: Virtual Congress 2021 – Imaging Year: 2021